Humana Inc.:企業の戦略・SWOT・財務分析

◆英語タイトル:Humana Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4082
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Humana Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Humana Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Humana Inc. (Humana or ‘the company’) is one of the leading providers of insurance products and health and wellness services. The company’s product portfolio includes prescription drug plan, Medicare Advantage plan, Medicare supplement insurance plans, and Medicare plan tools. Humana offers products and services for family and individuals such as life insurance, medical plans, vision plans, dental plans, and life and supplemental plans, among others. The company headquartered in Louisville, Kentucky, the US.

Scope

- Detailed information on Humana Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Humana Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Humana Inc. including a breakdown and examination of key business segments
- Intelligence on Humana Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Humana Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Humana Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Humana Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Humana Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Humana Inc.: Company Overview
Humana Inc.: Overview and Key Facts
Humana Inc.: Overview
Humana Inc.: Key Facts
Humana Inc.: Key Employees
Humana Inc.: Key Employee Biographies
Humana Inc.: Major Products and Services
Humana Inc.: Company History
Humana Inc.: Management Statement
Humana Inc.: Locations and Subsidiaries
Humana Inc.: Key Competitors
Humana Inc.: Company Analysis
Humana Inc.: Business Description
Humana Inc.: SWOT Analysis
Humana Inc.: SWOT Overview
Humana Inc.: Strengths
Humana Inc.: Weaknesses
Humana Inc.: Opportunities
Humana Inc.: Threats
Humana Inc.: Corporate Financial Deals Activity
Humana Inc.: Financial Deals Overview
Humana Inc.: Targets and Partners
Humana Inc.: Top Deals 2016 – 2020YTD*
Humana Inc.: Advisors
Humana Inc.: Top Legal Advisors
Humana Inc.: Top Financial Advisors
Humana Inc.: Mergers and Acquisitions
Humana Inc.: Corporate Venturing
Humana Inc.: Capital Raising
Humana Inc.: Partnership
Humana Inc.: Divestments
Humana Inc.: Recent Developments
Humana Inc.: News and Events Summary
Humana Inc.: Business Reorganization
Humana Inc.: Contracts
Humana Inc.: Grants
Humana Inc.: Regulatory and Legal Events
Humana Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Humana Inc.: Key Facts
Table 2: Humana Inc.: Key Employees
Table 3: Humana Inc.: Company History
Table 4: Humana Inc.: Locations and Subsidiaries
Table 5: Humana Inc.: Key Competitors
Table 6: Humana Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Humana Inc.: M&A Activity by Geography (TTM*)
Table 8: Humana Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Humana Inc.: M&A Average Deal Size - Value (US$m)
Table 10: Humana Inc.: Targets and Partners
Table 11: Humana Inc.: Top Deals 2016 - 2020YTD*
Table 12: Humana Inc.: Legal Advisor Ranking by Value (US$m)
Table 13: Humana Inc.: Financial Advisor Ranking by Value (US$m)
Table 14: Humana Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Humana Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Humana Inc.: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 17: Humana Inc.: Corporate Venturing by Geography (2016 - YTD*2020)
Table 18: Humana Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 19: Humana Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 20: Humana Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 21: Humana Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 22: Humana Inc.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 23: Humana Inc.: Divestments by Geography (2016 - YTD*2020)
Table 24: Humana Inc.: News and Events Summary
Table 25: Humana Inc.: Business Reorganization
Table 26: Humana Inc.: Contracts
Table 27: Humana Inc.: Grants
Table 28: Humana Inc.: Regulatory and Legal Events
Table 29: Humana Inc.: Strategy and Operations

★海外企業調査レポート[Humana Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bancolombia S.A.:企業の戦略・SWOT・財務分析
    Bancolombia S.A. - Strategy, SWOT and Corporate Finance Report Summary Bancolombia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Avid Technology Inc (AVID):企業の財務・戦略的SWOT分析
    Avid Technology Inc (AVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • TRACOE medical GmbH:企業の戦略的SWOT分析
    TRACOE medical GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • China Banking Corporation:企業の戦略・SWOT・財務情報
    China Banking Corporation - Strategy, SWOT and Corporate Finance Report Summary China Banking Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Neusoft Medical Systems Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Neusoft Medical Systems Co Ltd (Neusoft Medical), a subsidiary of Neusoft Corp is a medical device company that provides medical equipment and services. The company offers medical imaging equipment, e-hospital solutions, regional medical and personal healthcare products. Its product portfoli …
  • University of Pittsburgh Medical Center:医療機器:M&Aディール及び事業提携情報
    Summary University of Pittsburgh Medical Center (UPMC) is a health care provider organization. It is a non-profit health care firm comprising a wide network of hospitals, clinics, and long-term care, rehabilitation and retirement facilities. The company offers several services such as commercial, me …
  • DSW Inc.:戦略・SWOT・企業財務分析
    DSW Inc. - Strategy, SWOT and Corporate Finance Report Summary DSW Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Evraz Plc:企業のM&A・事業提携・投資動向
    Evraz Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Evraz Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Serco Group plc (SRP):企業の財務・戦略的SWOT分析
    Serco Group plc (SRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Oncobiologics Inc (ONS):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncobiologics Inc (Oncobiologics) is a clinical stage biopharmaceutical company that identifies, develops, manufactures and commercializes biosimilar therapeutics in the areas of immunology and oncology. The company's pipeline products include ONS-3010, an adalimumab biosimilar intended for …
  • PPL Corporation (PPL):石油・ガス:M&Aディール及び事業提携情報
    Summary PPL Corp (PPL) is an energy holding company. Through its subsidiaries, LG&E, Kentucky Utilities, and KU Energy, it generates, transmits, distributes, and sells electricity; and distributes and sells natural gas. The company produces electricity from coal, natural gas, oil, hydro, and solar s …
  • Princess Cruise Line Ltd:企業の戦略・SWOT・財務情報
    Princess Cruise Line Ltd - Strategy, SWOT and Corporate Finance Report Summary Princess Cruise Line Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Bioanalytical Systems Inc (BASI):企業の財務・戦略的SWOT分析
    Summary Bioanalytical Systems Inc (Bioanalytical Systems) is a contract research organization. It provides drug discovery and development services, and analytical instruments. The company’s contract research services include screening and pharmacological testing, formulation development, preclinical …
  • Mereo Biopharma Group Plc (MPH):企業の財務・戦略的SWOT分析
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • MSM Malaysia Holdings Berhad (MSM):企業の財務・戦略的SWOT分析
    MSM Malaysia Holdings Berhad (MSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Skanska AB (SKA B):企業の財務・戦略的SWOT分析
    Skanska AB (SKA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Bandwidth Inc (BAND):企業の財務・戦略的SWOT分析
    Bandwidth Inc (BAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Autobio Diagnostics Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Autobio Diagnostics Co Ltd (Autobio) is a clinical diagnostic company that offers research and development; production and distribution of clinical diagnostic products. The company’s products include immunoassays, mycoplasma, blood culture bottle, bacterial vaginosis, microplate luminometer, …
  • Ardelyx Inc (ARDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company provides product portfolio such as tenapanor, RDX227675, RDX98940 and RDX013, among others. Its products are used for hyperphosphatemia in …
  • Nolato AB (NOLA B):企業の財務・戦略的SWOT分析
    Nolato AB (NOLA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆